Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Phase 1 Trial Results for Patients with Advanced Hematologic Malignancies Undergoing Reduced Intensity Allogeneic HCT with Orca-T Donor Cell Therapy Product and Single Agent Tacrolimus

Blood (2023) 142 (Supplement 1): 3560.

https://doi.org/10.1182/blood-2023-188162

Published: 2023

Journal Articles

Sequencing-Based Minimal Residual Disease Assessment In T-Cell Malignancies: T-Cell Prolymphocytic Leukemia Case Study

Katherine Sutherland, Katherine Kong, Aaron C. Logan, MD, PhD, Malek Faham, MD, PhD, David B. Miklos, MD, PhD

Blood (2013) 122 (21): 1392.

https://doi.org/10.1182/blood.V122.21.1392.1392

Published: 2013

Journal Articles

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression

Michael Krathen, MD, Uma Sundram, MD, PhD, Sameer Bashey, MD, Katherine Sutherland, C-PA, Katrin Salva, MD, Gary S Wood, MD, Ranjana H. Advani, MD, Richard T. Hoppe, MD, Sunil Reddy, MD, Randall Armstrong, Seema Nagpal, MD, Melissa Pulitzer, MD, Steven M. Horwitz, MD, Youn H. Kim, MD

Blood (2012) 120 (21): 797.

https://doi.org/10.1182/blood.V120.21.797.797

Published: 2012

Journal Articles

Development of a Quality of Life Instrument Specific for Cutaneous Lymphoma

Eleni Linos, MD DrPH, Youn H Kim, MD, Sareeta R S Parker, MD, Katherine Sutherland, Suephy C Chen, MD MS

Blood (2011) 118 (21): 3158.

https://doi.org/10.1182/blood.V118.21.3158.3158

Published: 2011

Journal Articles

Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome

Wen-Kai Weng, MD, PhD, Randy Armstrong, Sally Arai, MD, Katherine Sutherland, Richard T. Hoppe, MD, Youn H. Kim, MD

Blood (2011) 118 (21): 3114.

https://doi.org/10.1182/blood.V118.21.3114.3114

Published: 2011

NARROW

Phase 1 Trial Results for Patients with Advanced Hematologic Malignancies Undergoing Reduced Intensity Allogeneic HCT with Orca-T Donor Cell Therapy Product and Single Agent Tacrolimus

Sequencing-Based Minimal Residual Disease Assessment In T-Cell Malignancies: T-Cell Prolymphocytic Leukemia Case Study

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression

Development of a Quality of Life Instrument Specific for Cutaneous Lymphoma

Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome

Email alerts

ASH Publications

American Society of Hematology

Phase 1 Trial Results for Patients with Advanced Hematologic Malignancies Undergoing Reduced Intensity Allogeneic HCT with Orca-T Donor Cell Therapy Product and Single Agent Tacrolimus

Sequencing-Based Minimal Residual Disease Assessment In T-Cell Malignancies: T-Cell Prolymphocytic Leukemia Case Study

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression

Development of a Quality of Life Instrument Specific for Cutaneous Lymphoma

Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only